Portfolio: Investments

iPierian
Drug discovery and development company harnessing cellular reprogramming breakthroughs

KaloBios Pharmaceuticals, Inc.
Therapeutic antibody development

Ligand Pharmaceuticals, Inc. (FNA Metabasis Therapeutics, Inc.)
Liver and metabolic diseases linked to liver pathways

Macrogenics, Inc.
Improved therapeutic antibodies

NeoVista, Inc.
Specialized device for wet form of Age-Related Macular Degeneration

NeuroTherapeutics Pharma, Inc.
Developing therapies for diseases associated with central nervous system (CNS) hyper-excitability